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Abstract
Background: DNA microarrays provide a powerful method for global analysis of gene expression. The application of
this technology to specific cell types and tissues, however, is typically limited by small amounts of available mRNA,
thereby necessitating amplification. Here we compare microarray results obtained with two different methods of RNA
amplification to profile gene expression in the C. elegans larval nervous system.
Results: We used the mRNA-tagging strategy to isolate transcripts specifically from C. elegans larval neurons. The WT-
Ovation Pico System (WT-Pico) was used to amplify 2 ng of pan-neural RNA to produce labeled cDNA for microarray
analysis. These WT-Pico-derived data were compared to microarray results obtained with a labeled aRNA target
generated by two rounds of In Vitro Transcription (IVT) of 25 ng of pan-neural RNA. WT-Pico results in a higher fraction
of present calls than IVT, a finding consistent with the proposal that DNA-DNA hybridization results in lower mismatch
signals than the RNA-DNA heteroduplexes produced by IVT amplification. Microarray data sets from these samples
were compared to a reference profile of all larval cells to identify transcripts with elevated expression in neurons. These
results were validated by the high proportion of known neuron-expressed genes detected in these profiles and by
promoter-GFP constructs for previously uncharacterized genes in these data sets. Together, the IVT and WT-Pico
methods identified 2,173 unique neuron-enriched transcripts. Only about half of these transcripts (1,044), however, are
detected as enriched by both IVT and WT-Pico amplification.
Conclusion: We show that two different methods of RNA amplification, IVT and WT-Pico, produce valid microarray
profiles of gene expression in the C. elegans larval nervous system with a low rate of false positives. However, our results
also show that each method of RNA amplification detects a unique subset of bona fide neural-enriched transcripts and
thus a wider array of authentic neural genes are identified by the combination of these data sets than by the microarray
profiles obtained with either method of RNA amplification alone. With its relative ease of implementation and greater
sensitivity, WT-Pico is the preferred method of amplification for cases in which sample RNA is limiting.
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Background
The human brain is comprised of diverse classes of neu-
rons, and many of these neural classes are conserved
throughout evolution. Our understanding of the molecu-
lar basis for these differences would be greatly advanced
by a gene expression map of the nervous system. In prin-
ciple, this information could be compiled from high den-
sity microarray experiments that catalog transcripts
expressed in each class of neuron [1,2]. This approach
necessarily requires, however, methods for extracting tran-
scripts from individual cell types. Several approaches are
now available for overcoming this technical hurdle. Laser
Capture Microdissection (LCM) [3] and FACS (Fluores-
cence Activated Cell Sorting) [4] have been used to isolate
specific neurons for RNA extraction. For example, specific
GFP-labeled neurons and muscle cells have been obtained
by FACS from the nematode, C. elegans, for microarray
gene expression profiling experiments [5-9]. In several
instances, disruption of specific genes included in these
data sets revealed key functional roles in the profiled cell
type [5]. A recently developed alternative biochemical
strategy is also available for extracting RNA from specific
cells that may not be readily dissociated for FACS. In this
"mRNA-tagging" approach, an epitope-labeled mRNA
binding protein (FLAG-PAB-1) is transgenically expressed
with a cell-specific promoter. Bound mRNA is then
obtained by co-immunoprecipitation with the FLAG-PAB-
1 protein [10]. This method has been utilized to profile
tissues and cell types in C. elegans and in Drosophila [8,10-
14]. Thus, robust physical and biochemical methods are
now available for obtaining mRNA from specific types of
neurons in several different organisms. The limited
amount of RNA (< 1 ug) available from these approaches,
however, typically requires amplification before microar-
ray analysis [15]. One method of amplification, PCR
based exponential amplification, can generate microgram
quantities of cDNA from as little as 1 ng of total RNA. PCR
based methods, however, have been shown to be less
reproducible than linear amplification methods, such as
In Vitro Transcription (IVT) [16]. IVT has been widely uti-
lized for RNA amplification [17]. In this approach, cDNA
is initially synthesized to provide a template for amplifi-
cation by T7 RNA polymerase. In most cases, two rounds
of cDNA synthesis and IVT are required to generate suffi-
cient aRNA (> 10 ug) for microarray hybridization. We
have used the IVT method to produce robust gene expres-
sion profiles of C. elegans neurons and muscle cells
[6,8,9,12,18]. In some instances, it was difficult to obtain
enough RNA for reliable IVT amplification; in other cases
IVT failed for unknown reasons (JDW, SEV and DMM,
unpublished data). Thus, we needed a more sensitive and
reliable method of RNA amplification. Here we describe
microarray results obtained with RNA amplified by WT-
Ovation Pico, an isothermal linear amplification system
(WT-Pico) [19-22]. For the first step in this protocol (Fig.
1), cDNA is synthesized with a combination of a Poly-dT
and random primers. cDNA synthesis primers and the
amplification primer are chimeric DNA/RNA oligonucle-
otides, comprising 3'-DNA and a 5'-RNA sequences. Sec-
ond strand cDNA synthesis produces a complementary
DNA/RNA duplex adjacent to the 1st strand-priming site.
Treatment with RNase H selectively removes the RNA
sequence from the heteroduplex and provides a unique
priming site for cDNA amplification. A chimeric amplifi-
cation primer hybridizes to this priming site and is
extended by DNA polymerase with strand displacement
activity to generate a new cDNA strand. The RNA portion
of the hybridized primer is removed by RNase H and the
cycle is re-initiated by annealing of the amplification chi-
meric primer (SPIA primer). The net result is synthesis of
multiple copies of cDNA in a single amplification step.
The WT-Pico system offers the advantage of requiring less
time and fewer steps than the IVT amplification [19]. In
addition, the DNA target generated by WT-Pico amplifica-
tion is reported to result in more efficient and specific
hybridization with DNA probe sets than the labeled aRNA
target produced with IVT amplification [23,24]. We uti-
lized the WT-Pico method to amplify RNA extracted from
the  C. elegans nervous system by the mRNA-tagging
method and compared microarray data from this sample
to a previously reported pan-neural profile generated with
IVT amplification [8]. In our hands, robust microarray
data were obtained with WT-Pico amplification from 10-
fold less starting RNA than with IVT. In addition, we have
confirmed that the WT-Pico cDNA target results in a
greater dynamic range and improved signal/noise with
more present calls than with the IVT-generated aRNA tar-
get. Bioinformatic analysis and in vivo expression data
from promoter-GFP fusion genes established that the
gene expression profile generated with WT-Pico is highly
enriched for neuronal transcripts. The microarray data
from the pan-neural-derived samples amplified by the IVT
and WT-Pico methods identifies 2,173 transcripts with
elevated expression in the C. elegans nervous system.
mRNAs included in this neural-enriched sample encode
proteins with a broad array of predicted functions in the
C. elegans nervous system. Only ~50% of these transcripts,
however, are detected as enriched by both methods of
RNA amplification. On the basis of this result, we suggest
that the IVT and WT-Pico amplification methods show
significant nucleotide sequence bias and therefore that,
where possible, comprehensive gene expression profiles
should be based on more than one method of RNA ampli-
fication.
Results and discussion
A comparison of two amplification methods, WT-Pico and 
IVT
We used the WT-Pico method (Fig. 1) [20] to amplify RNA
obtained from all C. elegans neurons ("pan-neural") byBMC Genomics 2008, 9:84 http://www.biomedcentral.com/1471-2164/9/84
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Diagram of the ribo-SPIA process for the synthesis of sscDNA Figure 1
Diagram of the ribo-SPIA process for the synthesis of sscDNA. First strand cDNA is generated from template RNA 
using reverse transcriptase (RT) and two types of chimeric primers, random and oligo(dT), containing an RNA overhang (Step 
1). DNA Polymerase is added to the reaction to generate second strand cDNA (Step 2). sscDNA is amplified from the 
dscDNA template in a cycle in which a SPIA™ primer (DNA/RNA hybrid) anneals to the template, DNA Polymerase begins 
duplicating the cDNA, the RNA portion of the primer degraded by RNase H (which only degrades RNA when it is in a duplex 
with DNA), thus allowing another SPIA™ primer to bind to the template and restart the reaction (Step 3).
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the mRNA-tagging method [8,10]. Microarray data were
generated from five independent pan-neural RNA sam-
ples. A companion reference data set was obtained with
three replicates of RNA from all C. elegans cells. These
results were compared to microarray data previously
obtained from IVT-amplified samples [8]. Eight pan-neu-
ral and reference data sets were produced for each ampli-
fication method (Table 1). All WT-Pico amplification
reactions were performed with 2 ng of starting RNA
whereas the IVT amplifications utilized 25 ng of sample
RNA. Comparisons of signal intensities generated from
independent replicates showed that the WT-Pico-ampli-
fied pan-neural and reference samples are reproducible.
For example, the coefficient of determination for the five
pan-neural WT-Pico amplified samples, R2 = 0.96, com-
pares favorably to an R2 = 0.98 for the three IVT-generated
pan-neural profiles (Fig. 2a–d). Thus, these R2 values are
indicative of highly reproducible data sets.
We measured other parameters derived from the microar-
ray data to compare the performance of the WT-Pico vs
IVT-amplified targets. The C. elegans Affymetrix Gene
Chip includes 22,499 probe sets. On the Affymetrix Gene
Chip, each Perfect Match (PM) oligonucleotide is paired
with a MisMatch (MM) probe that includes a single base
pair substitution. The hybridization intensity of each MM
probe is subtracted from that of the paired PM probe to
correct for stray signal. An overall PM vs MM discrimina-
tion score for the probe set is calculated from these values
to distinguish between present, Marginal or Absent tran-
scripts [25] (See methods). Overall, hybridizations with
the WT-Pico amplified sample resulted in a greater
number of present calls than with the IVT target (Table 1).
For example, an average of 56% (~12,600) of probe sets
were scored as present in the pan-neural profiles obtained
by WT-Pico amplification whereas an average of only 41%
(~9,200) of probe sets were called present in the IVT-gen-
erated pan-neural data set (Table 1) (p < 0.05) (See Meth-
ods). A similar difference is noted from a comparison of
the fraction of transcripts detected on all of the pan-neural
arrays. In this case, WT-Pico amplification identifies 9,198
present transcripts whereas the IVT-derived target reports
7,382 present calls (Table 2) [See Additional file 1]. The
removal from these comparisons of duplicate probe sets
(i.e. probe sets for the same gene) resulted in a final differ-
ence of 7,409 present genes in the WT-Pico-derived data
set vs 6,354 present calls in the IVT profile (Table 2).
The greater number of present calls derived from the WT-
Pico data sets is correlated with the finding that the WT-
Pico target results in relatively less mismatch hybridiza-
tion than the IVT sample [23]. For the combined IVT-
amplified pan-neural and reference samples, we find that
29 ± 0.5% of MM signals exceed the paired PM value
whereas only 24 ± 1% of the WT-Pico derived signals
show MM > PM ratios (p < 0.01) (Fig. 3). Similar results
have been noted previously and attributed to the finding
that mismatched RNA:DNA heteroduplexes are thermo-
dynamically more stable than comparable DNA:DNA
hybrids [23,24].
Neuron-enriched transcripts are identified in both the WT-
Pico and IVT-amplified samples
To test the ability of the WT-Pico-amplified sample to
detect differentially expressed transcripts, the pan-neural
data set was compared to the reference profile obtained
from all cells (see Methods). As expected, scatter plots
reveal significant differences between these data sets with
1,625 transcripts showing elevated intensity values in the
pan-neural sample vs 1,325 depleted mRNAs (Fig. 2e)
[See Additional file 2]. (Similar results (Fig. 2f) were
obtained by the IVT amplification method [8]). As an
independent test of the validity of these data, the list of
1,625 transcripts showing elevated intensity values in the
WT-Pico derived Pan-neural data set (i.e., "enriched
genes") was compared to WormBase to identify the subset
of transcripts previously described as expressed in neurons
[8].
This analysis revealed 520 transcripts in the WT-Pico-
amplified data set with known expression patterns in vivo.
Of these, 85% are annotated in WormBase as expressed in
neurons (Fig. 4). This finding is comparable to the obser-
vation that 90% of the 524 transcripts in the enriched IVT-
amplified pan-neural profile with expression data in
WormBase are also detected in neurons [See Additional
file 3]. In both cases, the microarray profiles show a signif-
icant bias for authentic neuronal transcripts as only 55%
of all genes with expression patterns listed in WormBase
are neuronal (Fig. 4) [See Additional file 4]. These find-
ings confirm that both the WT-Pico and IVT amplification
methods detect transcripts that are differentially expressed
in the C. elegans nervous system.
To estimate the concordance of these data, we compared
normalized intensity values for differentially expressed
transcripts identified by each method. Log2 of the IVT
pan-neural/reference ratio was plotted versus that of the
WT-Pico/reference (Fig. 5) for probe sets with present calls
in all of the pan-neural samples (see Methods) [See Addi-
tional file 5]. The R2 value of 0.72 is indicative of signifi-
cant correlation between these two amplification
methods for the subset of transcripts that are detected in
both, an outcome similar to that seen in previous compar-
isons of WT-Pico vs IVT [20,24].
We expanded this comparison to consider all probe sets
on the C. elegans chip. These results are depicted in Fig. 6
in the form of a line graph in which the intensity values
for all three of the IVT pan-neural replicates and for theBMC Genomics 2008, 9:84 http://www.biomedcentral.com/1471-2164/9/84
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Microarray data derived from WT-Pico amplified pan-neural samples are reproducible and enriched for neural genes Figure 2
Microarray data derived from WT-Pico amplified pan-neural samples are reproducible and enriched for neural 
genes. A-B. Pairwise comparisons of individual hybridizations. Coefficient of determination (R2) values for A., all pairwise 
combinations of reference hybridizations and for B., all pairwise combinations of larval pan-neural data sets are indicative of 
reproducible results for both reference and experimental samples. C. Scatter plot of intensity values (log2) for a representative 
hybridization (298-DMM-8) (red) isolated from all larval cells (reference) compared to the average intensity of the reference 
data set (green). D. Scatter plot (log2) of representative pan-neural hybridization (298-DMM-3) (red) compared to the average 
intensities for all five pan-neural hybridizations (green). E. A representative WT-Pico-amplified pan-neural sample (298-DMM-
3) (red) compared to the average of WT-Pico amplified reference samples (green). F. A representative IVT-amplified pan-neu-
ral sample (DMW43) (red) compared to the average of IVT-amplified reference samples (green). R2 = Coefficient of determina-
tion. Selected genes enriched in both the WT-Pico-amplified and IVT-amplified pan-neural samples are: snb-1(synaptobrevin), 
flp-11 (neuropeptide); unc-30 (homeodomain trancription factor). Transcripts exclusively enriched in the WT-Pico sample 
include rpm-1 (E3 ubiquitin ligase) and pag-3 (Zn-finger transcription factor). The nicotinic acetylcholine receptor unc-38 is 
selectively enriched in the IVT data set. Examples of transcripts that are depleted in both pan-neural samples are: him-4 (hemi-
centin, body muscle), myo-2 (myosin heavy chain, pharyngeal muscle), myo-3 (myosin heavy chain, body wall muscle).
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five WT-Pico pan-neural samples are normalized against
the corresponding average reference intensities. Lines are
color coded as enriched (red), depleted (blue) or
unchanged (yellow) relative to the reference. Colors for
each gene are fixed by the relative values of sample #3
(vertical bold white line) in the WT-Pico data set. This glo-
bal analysis suggests an overall trend in which transcripts
detected by both methods show similar patterns of differ-
ential expression. For example, 53 transcripts enriched in
the IVT-derived pan-neural sample encode proteins with
established or likely functions in neurotransmitter release
at the synapse [8]. 37 (70%) of these genes are also
enriched in the WT-Pico pan-neural data set and essen-
tially all of these transcripts show intensity values greater
than or equal to the reference (Fig. 6B). Similar results
were obtained for transcripts encoding FMRFamide-like
proteins (flps), a large family of peptide neurotransmitters
that are largely restricted to the C. elegans nervous system
(Fig. 6C) [26]. In addition to identifying similar trends in
the relative intensity values of specific transcripts obtained
by both methods, these line graphs also reveal a difference
in the apparent overall spread of hybridization signals
with the WT-Pico results showing a significantly larger
dynamic range of differential expression vs the IVT data
set (Fig. 6A, B). A similar result was obtained in a previous
comparison of IVT vs WT-Pico derived microarray data
[23].
WT-Pico and IVT amplified targets reveal distinct neural 
transcripts
A comparison of the pan-neural enriched transcripts
detected in these microarray experiments identifies a core
group of 1,044 genes that are detected by both the IVT and
WT-Pico methods (Fig. 7) [See Additional file 6]. This
analysis also revealed, however, that a comparable
number of transcripts is selectively enriched in either the
WT-Pico or IVT derived data sets; 581 transcripts are
detected as enriched in the WT-Pico pan-neural sample
but not in the IVT data set whereas 548 genes are specifi-
cally enriched in the IVT pan-neural profile but not in the
WT-Pico pan-neural data set [See Additional file 6]. These
findings were validated by comparison to independently
derived data that measures the expression and function of
these genes in the C. elegans nervous system in vivo. First,
we established that a majority of genes in either the IVT-
only or WT-Pico-only pan-neural enriched data sets with
known expression patterns in WormBase are annotated as
expressed in neurons (Fig. 7). Additional genetic data
have established specific neural functions for a subset of
these differentially detected genes. For example, the WT-
Pico-only subset of pan-neural enriched transcripts
includes rpm-1, an E3 ubiquitin ligase that regulates syn-
aptic assembly (Fig. 2e) [27,28]. Similarly, the transcripts
encoding the transmembrane protein MIG-13, which
affects migration of the Q neuroblast and its descendants,
is enriched exclusively in the IVT data set (Fig. 2f) [29].
These findings suggest that each method of RNA amplifi-
cation may result in the detection of a unique subset of
bona fide pan-neural enriched genes. We tested this idea by
constructing GFP reporters for a representative set of genes
listed in either the WT-Pico only or IVT pan-neural only
enriched data sets (Table 3). In this approach, the
upstream promoter or regulatory region of a specific gene
is fused to GFP and reintroduced into the organism to
monitor expression in the intact animal (see Methods).
Nine transgenic lines were constructed from the WT-Pico-
only data set. Neuronal GFP expression was confirmed in
all 9 of these lines with reporters for two genes (ZC155.2,
C07H6.1) showing GFP expression exclusively in neurons
(Fig. 8). Similarly, 7 out of 8 (Table 3) GFP reporters for
genes in the IVT-only neural enriched data set show
expression in C. elegans neurons in vivo (Fig. 8). Thus,
these results support the conclusion that the pan-neural
enriched data sets generated by each of these methods are
reliably detecting transcripts expressed in the C. elegans
nervous system.
Table 1: Hybridization and amplification summaries for WT-Pico and IVT amplifications
Amplification method 
and sample type
Starting 
Material (ng)
Average 
Yield (ug)
Average 
yield/ng
No. of 
Chips
Scale 
Factor
Average 
Intensity 
Values
Affymetrix average 
present calls/chip
IVT neural 25 44.8 1.8 3 4.4 817.0 41.4
IVT reference 25 38.8 1.6 5 5.4 898.6 42.1
WT-Pico neural 2 10.5 5.3 5 9.6 841.2 56.1
WT-Pico reference 2 7.6 3.8 3 16.4 991.2 46.7
Table 2: Total number of transcripts identified by RNA 
amplification
Amplification method 
and sample type
Total number of 
present probesets
Total number of 
present genes
IVT neural 7382 6354
IVT reference 7325 6302
WT-Pico neural 9198 7409
WT-Pico reference 7771 6238BMC Genomics 2008, 9:84 http://www.biomedcentral.com/1471-2164/9/84
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Signal/Noise is enhanced with WT-Pico vs IVT-amplified targets Figure 3
Signal/Noise is enhanced with WT-Pico vs IVT-amplified targets. MisMatch (MM) signals were higher than Perfect 
Match (PM) intensities more frequently with IVT-amplified samples than with WT-Pico-amplified targets. Chart represents 
average MM/PM signal intensities from all microarray samples.
Established neuron-expressed transcripts are highly represented in WT-Pico and IVT-amplified pan-neural samples Figure 4
Established neuron-expressed transcripts are highly represented in WT-Pico and IVT-amplified pan-neural 
samples. A. Histrogram showing percent annotated genes in microarray data sets with known in vivo expression in neurons. 
All genes with known cellular expression patterns listed in WormBase were used for this comparison. Note significant enrich-
ment for neuronal genes in both the WT-Pico and IVT-amplified pan-neural samples (85–90%) relative to the fraction of anno-
tated genes in WormBase (55%) that show some expression in the C. elegans nervous system. B. Summary of expression data 
from transcripts enriched in WT-Pico and IVT-amplified pan-neural samples. (FDR = False Discovery Rate, see Methods).BMC Genomics 2008, 9:84 http://www.biomedcentral.com/1471-2164/9/84
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The WT-Pico and IVT amplified samples identify C. 
elegans genes with homologs expressed in the mammalian 
brain
Microarray analysis of the IVT-amplified pan-neural sam-
ple detected 1,592 transcripts with elevated expression in
C. elegans neurons [8] [See Additional file 3]. The inde-
pendent microarray profile of these samples generated
with the WT-Pico method has now identified an addi-
tional set of 581 neuron-enriched genes to yield a total of
2,173 transcripts that are highly expressed in the C. elegans
nervous system (Fig. 7). Thus, the use of two alternative
methods of RNA amplification has significantly expanded
(~36%) the list of transcripts that are differentially
expressed in C. elegans neurons. To assess the potential
value of these additional data for studies of gene function
in the nervous system, we identified a subset of genes in
the WT-Pico-only list that are evolutionarily conserved
but for which biochemical functions have not been previ-
ously assigned. This analysis yielded a total of 39 unchar-
acterized, highly conserved genes [See Additional file 7].
To determine if these transcripts are also expressed in
mammalian neurons, we searched the Allen Brain Atlas,
an online in situ hybridization database, for evidence of
expression in the mouse brain [30]. in situ data are availa-
ble for 27 apparent homologs of the C. elegans genes on
our list of WT-Pico-only enriched transcripts; 74% of
these genes (20/27) show expression in the mouse brain.
In the case of the IVT-only enriched transcripts, all seven
of the uncharacterized, conserved genes for which in situ
data are available in the Allen Brain Atlas are annotated as
expressed in the mouse brain [8]. These results support
the idea that genes that are uniquely detected by one of
these amplification methods are likely to encode authen-
tic neural transcripts and that these combined data can
provide potentially valuable clues to gene expression in
the human brain.
3' bias does not account for differentially enriched targets 
identified by either WT-Pico or IVT
WT-Pico uses a combination of Poly-dT and random
priming to amplify RNA. In contrast, the first round of the
IVT is limited to Poly-dT priming. We speculated that this
inherent difference in the amplification procedures might
bias IVT towards probesets near the 3' end of a transcript.
To test this hypothesis, each probeset identified as
enriched by only IVT or only WT-Pico was mapped with
Correlation of differential gene expression between WT-Pico and IVT-amplified samples Figure 5
Correlation of differential gene expression between WT-Pico and IVT-amplified samples. Average ratios (log2 of 
pan-neural/reference) of RMA-normalized intensity values are plotted for transcripts scored as present in all eight pan-neural 
arrays (WT-Pico = 5, IVT = 3). A linear least squares fit (black line) and coefficient of determination (R2) are shown.BMC Genomics 2008, 9:84 http://www.biomedcentral.com/1471-2164/9/84
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the BLAT tool [31] to a unique chromosomal location in
the WS170 assembly. From this position, we calculated
the distance from the 3' end of the probeset to the 3' end
of the gene it targets [See Additional file 8]. No statistically
significant difference was found between the locations of
the probesets unique to the WT-Pico method and those
unique to the IVT method (p = 0.75). We therefore con-
clude that differential hybridization of WT-Pico vs IVT-
generated targets is not due to a systematic bias of either
amplified sample for probe sets near the 3' end of targeted
transcripts. It should be noted however, that the probe
sets in the GeneChip expression arrays used in this study
are largely directed towards the 3'-end of the transcripts
and therefore would not detect WT-Pico derived targets
originating from more 5' regions. In the future, it will be
interesting to examine transcripts that are independently
detected with either IVT or WT-Pico-derived samples for
potential nucleotide sequences that could exert differen-
Similar overall patterns of differential gene expression are observed for WT-Pico and IVT-amplified pan-neural samples Figure 6
Similar overall patterns of differential gene expression are observed for WT-Pico and IVT-amplified pan-neu-
ral samples. A. Line graphs display log10 of relative intensity values (pan-neural/average reference) for all probes sets on the 
Affymetrix array. Each vertical line corresponds to a single pan-neural replicate (IVT = 3, WT-Pico = 5). Colors from the heat 
map at right are defined by the WT-Pico sample denoted by the bold vertical white line with arrowheads (298-DMM4). B. Line 
graph showing that most of the 53 [8] synaptic vesicle-associated genes are enriched (red) in the WT-Pico derived samples. C. 
22 of 23 FMRFamide-like neuropeptides (flps) enriched in the IVT sample also show elevated relative intensity values (red) in 
the WT-Pico data set.BMC Genomics 2008, 9:84 http://www.biomedcentral.com/1471-2164/9/84
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tial effects on either RNA amplification or target hybridi-
zation.
Conclusion
We have confirmed that the WT-Pico method affords
rapid and efficient RNA amplification with a higher frac-
tion of present calls after microarray hybridization than
targets amplified by the IVT protocol. The WT-Pico
method is also technically easier to implement than IVT
and requires significantly less time to perform. Although
both approaches generate robust microarray profiles of
gene expression in the C. elegans nervous system, a signif-
icant fraction of authentic neuron-enriched transcripts are
uniquely identified by each of these methods of RNA
amplification. Thus, the combined result obtained with
both amplification strategies provides a more complete
picture of neural gene expression than either sample
alone. For cases in which RNA is limiting, as in the effort
to profile single neuron types from C. elegans, the
enhanced sensitivity of the WT-Pico method is advanta-
geous.
Methods
Nematode strains
Nematodes were grown as described [32]. Strains used to
isolate transcripts via mRNA-tagging were N2 (wildtype
Bristol strain) and SD1241 (gaIs153, F25B3.3::FLAG::PAB-
1) [8].
Generating transgenic lines expressing GFP reporter genes
Promoter-GFP fusion genes were obtained from the Pro-
moterome project and transgenic lines generated by
microparticle bombardment as described [6]. Additional
file 9 contains a list of strains described in this paper.
mRNA-tagging and RNA amplification
The "in vitro transcribed" or "IVT" microarray data sets
used in this paper are described in a previous publication.
To generate these data sets, 25 ng of RNA from three pan-
neural replicates and from five independent N2 (refer-
ence) samples was amplified by the IVT method [8]. 2 ng
of these RNAs was amplified using version 1 of the WT-
Ovation Pico System, which combines WT-Ovation™
Pico RNA Amplification System and target preparation
according to fragmentation and labeling section of Ova-
tion™ Biotin RNA Amplification and Labeling System as
described in the User Guides [33]. Two of the previously
prepared reference RNA preparations did not amplify by
WT-Pico. Two additional samples were isolated by the
mRNA-tagging method from the pan-neural transgenic
line, SD1241[8] for WT-Pico amplification to yield a total
of five pan-neural replicates and three reference samples
for the "WT-Pico" profiles. Thus, six of the eight pan-neu-
ral and reference data sets generated by each of the RNA
amplification methods (IVT or WT-Pico) were obtained
from identical RNA samples. A quantitative comparison
of microarray results obtained from the two new pan-neu-
ral RNA samples (DMM10 and DMM11) used for the WT-
Pico amplification vs the originally isolated pan-neural
preparations (DMM2, DMM3, DMM4) also used for the
IVT amplification [8] showed a broadly similar distribu-
tion of intensity values (R2 > 0.91) (see Fig 2).
Microarray data analysis
Microarray data were processed as described [8,9]. Briefly,
intensity values from each hybridization were scaled vs a
global average signal from the same array and normalized
by Robust Multichip Average analysis (RMA) [34]. To
identify differentially expressed transcripts, normalized
intensity values from the pan-neural data sets were com-
pared to a reference (from all larval cells) using Signifi-
cance Analysis of Microarray software (SAM) [35]. A two-
class unpaired analysis of the data was performed to iden-
tify neuron-enriched genes. Pan-neural enriched tran-
scripts in the IVT and WT-Pico-derived data set were
defined as 1.5X elevated vs the reference at a False Discov-
ery Rate (FDR) = 3%. An earlier report describing the IVT-
Comparison of IVT and WT-Pico derived data sets reveals  differentially enriched transcripts Figure 7
Comparison of IVT and WT-Pico derived data sets 
reveals differentially enriched transcripts. A Venn dia-
gram denoting 1044 transcripts enriched in both data sets, 
548 genes selectively elevated in the IVT-derived profile, and 
581 genes exclusively enriched in the WT-Pico-amplified 
sample. The percentage of neuron-expressed genes in each 
group with annotated expression in WormBase is noted as 
"Neural calls."
548 1044 581
74% 91% 90%
48% overlap
IVT WT-Pico
Neural calls:
WT-Pico and IVT Venn DiagramBMC Genomics 2008, 9:84 http://www.biomedcentral.com/1471-2164/9/84
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amplified pan-neural data set utilized a more stringent
FDR of 1% and therefore identified a smaller number of
pan-neural enriched transcripts (1,562 vs 1,592 in this
study) ([8], this work). The data discussed in this manu-
script are available in the NCBI Gene Expression Omni-
bus, series accession number GSE9485.
Promoter-GFP reporter genes confirm neural expression of transcripts from pan-neural enriched data sets Figure 8
Promoter-GFP reporter genes confirm neural expression of transcripts from pan-neural enriched data sets. 
Transgenic animals expressing GFP reporters for representative transcripts exclusively enriched in either the IVT derived data 
set (A-D) or the WT-Pico-amplified sample (E-L). A. F32B6.11::GFP is expressed throughout the C. elegans nervous system 
including neurons associated with the Nerve ring in the head, motor neurons throughout the Ventral Nerve Cord (VNC) and 
in tail ganglia. D. F49H12.4::GFP is selectively expressed in PVD nociceptive neuron and in two additional neurons in the tail 
region. Note the highly branched PVD dendritic architecture (arrowheads). E. Differential Interference Contrast (DIC) image 
of midbody region of 2nd stage larva (F.) expressing F47B8.3::GFP in GABAergic motor neurons (DD5, VD10, VD11) in the 
ventral nerve cord. P9 and P10 denote landmark hypodermal blast cells. G-H. ZC155.2::GFP and C50F4.4::GFP are expressed 
in VNC motor neurons (e.g. VA10, VB11, etc). Anterior to left, Ventral down. VNC (Ventral Nerve Cord).
ZK632.13::GFP
F49H12.4::GFP
Y106G6H.4::GFP
C50F4.4::GFP
F08B6.3::GFP
C07H6.1::GFP
F32B6.11::GFP
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Annotation of data sets and additional data analysis
Annotation was performed as previously described using
WormBase Release 170 http://WS170.wormbase.org.
Affymetrix GeneChip Operating Software (GCOS) was
used to calculate the average number of present calls for
each probe set (Table 1) [25]. Present calls listed in Table
2 and used to calculate Fig. 5 were identified with a Perl
script (consensus.pl) [See Additional file 10]. For a given
sample (e.g. IVT pan-neural) a transcript was scored
"present" if called present in all replicates. For Fig. 5.,
RMA-normalized intensities for these present genes were
averaged across all replicates. Average pan-neural/refer-
ence intensities were calculated for WT-Pico and IVT data
and log2 transformed. The coefficient of determination
(R2) for the resulting scatter plot was calculated in Micro-
soft Excel.
Mismatch (MM) intensities were compared against Perfect
Match (PM) intensities for both pan-neural and reference
samples using the Bioconductor [36] Affy package [36] for
Fig. 3.
RMA normalized intensity values for all data sets were
imported into GeneSpring GX 7.3 [37] to generate the line
graphs shown in Fig. 6. Each Experimental data set was
normalized vs the average intensity value for each probe
set in the corresponding reference data set and plotted as
log (Experimental/reference). Each vertical line represents
an individual replicate for each Experimental sample.
p-values for total yield, number of present genes, and per-
fect vs mismatch probes were calculated using a two-tailed
t-test with unequal variance.
3' bias analysis
IVT-only and WT-Pico only enriched transcripts were
examined for 3' bias. C_elegans_target.fa was down-
loaded from Affymetrix. This file contains the reference
sequence for each probeset on the array. The file
Caenorhabditis_elegans.WB170.45.dna.seqlevel.fa was
downloaded from Ensembl (Ensembl 45, based on
Wormbase 170). Probesets were aligned to chromosomes
using BLAT [31]. Where multiple alignments were found,
the alignment that covered the longest portion of the
probeset sequence was chosen. The genes and chromo-
somal locations of those genes were downloaded using
Ensembl 45. The probeset distance from the 3' end of the
gene was calculated. For genes on the (+) strand, the dis-
tance is given as (Gene End) – (Probeset End). For genes
on the (-) strand, the distance is given as (Probeset Start)
– (Gene Start). For probesets that correspond to multiple
genes, the gene with the smallest absolute value of 3' dis-
tance was chosen. p-value was calculated using a 2-tailed
t-test with equal variance.
Table 3: Expression of promoter-GFP reporters for transcripts enriched in larval pan-neural or A-class motor neuron data sets.
Cosmid Gene KOG (other description) IVT Fold 
Change
WT-Pico Fold Change In Neurons?
IVT only
F30F8.2 Glutaminase 1.6 -- √
F32B6.11 Unnamed Protein 2.5 -- √
F49H12.4 (novel) 2.6 -- √
H01A20.1 nhr-3 Nuclear Hormone Receptor 1.7 -- √
R09F10.5 (novel) 2.3 -- √
T19C4.5 (novel) 2.0 -- No expression
W01H2.3 rab-37 (Rab GTPase) 6.9 -- √
Y106G6H.4 Unnamed Protein 1.9 -- √
WT-Pico only
C50F4.4 (novel) -- 2.0 √
F08B6.3 Reticulocalbin, calumenin, DNA supercoiling factor, and 
related Ca2+-binding proteins of the CREC family (EF-Hand 
protein superfamily)
-- 2.7 √
K10B2.4 Predicted membrane protein -- 1.6 √
ZK632.13 lin-52 Uncharacterized conserved protein -- 2.9 √
C07H6.1 lig-4 ATP-dependent DNA ligase IV -- 2.9 √
F08G12.1 GTPase Rab1/YPT1, small G protein superfamily, and related 
GTP-binding proteins
-- 3.6 √
F47B8.3 Glutaredoxin-related protein -- 2.0 √
T20G5.10 General control of a.a. synthesis 5-like 1 -- 2.7 √
ZC155.2 (putative nucleosome assembly factor) -- 2.8 √
GFP expression was typically determined in L2 larvae. Full expression pattens can be found in Additional file 9.BMC Genomics 2008, 9:84 http://www.biomedcentral.com/1471-2164/9/84
Page 13 of 14
(page number not for citation purposes)
Microscopy and identification of GFP expressing cells
GFP-expressing animals were visualized by Differential
Interference Contrast (DIC) and epifluorescence optics in
either a Zeiss Axioplan or Axiovert compound micro-
scope. Digital images were recorded with CCD cameras
(ORCA I or ORCA ER, Hamamatsu Corporation, Bridge-
water, NJ).
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